GLP-1 Drug Interactions: Medications That Change How These Injections Work

You packed your Ozempic pen alongside your blood pressure tablets, thyroid medication, and contraceptive pill. You are two weeks into a Laguna resort stay, eating less than usual because the injection is doing exactly what it should, and your blood glucose just came back lower than it has ever been. Or your period is late. Or your INR reading came back odd at your last check. These things do not usually happen by accident.

GLP-1 receptor agonists, the class that includes semaglutide and tirzepatide, work partly by slowing how fast food leaves your stomach. That same mechanism changes how your body absorbs every other tablet you swallow. The interactions are not always dramatic, but some matter enough to adjust doses, change timing, or switch contraception methods. Here is what you need to know, drug by drug.

How Slowed Gastric Emptying Changes Oral Medication Absorption

The stomach delay is the central issue. When a GLP-1 drug slows gastric emptying, oral medications sit in the stomach longer before reaching the small intestine, where most absorption happens. For most drugs this is a small, manageable shift. For drugs where the gap between enough and too much is already tight, even a modest change in timing matters.

Warfarin is one example. Levothyroxine is another. Oral contraceptive hormones are a third. The change does not always reduce the total amount absorbed. More often it shifts the timing of peak levels, and that shift is enough to cause problems when a drug needs consistent, predictable blood levels to work properly.

The risk is highest during the dose escalation phase, when GLP-1 doses step up roughly every four weeks. Each increase intensifies the gastric emptying delay. If you changed your GLP-1 dose in the last month and you are on any of the medications below, that timing matters.

GLP-1 Drug Interactions With Diabetes Medications

This is the interaction that carries the most immediate risk. GLP-1 drugs lower blood glucose on their own. Combining them with insulin or a sulfonylurea, drugs like glipizide or gliclazide that also push glucose down, stacks that effect. Low blood glucose, called hypoglycemia, can follow.

Prescribing guidance for both semaglutide and tirzepatide states that insulin doses may need to be reduced when a GLP-1 is added. The same applies to sulfonylureas. Blood glucose monitoring becomes more important during the early weeks, not less. If you are adjusting doses without a physician involved, that warrants same-day clinical assessment at a walk-in doctor in Phuket rather than a wait-and-see approach.

Dizziness, sweating, confusion, or shaking after eating less than usual are signs that your glucose may be low. Phuket’s heat and the risk of dehydration can make glucose instability worse than you expect indoors in a cooler climate.

GLP-1 and Thyroid Medication: Levothyroxine Timing and Absorption

Levothyroxine absorption is sensitive to food, other tablets, and gastric emptying rate. Injectable semaglutide and tirzepatide can alter absorption timing through gastric delay alone. Oral semaglutide (Rybelsus) creates an additional problem: the Rybelsus prescribing information shows it can increase total levothyroxine exposure by approximately 33% and reduce the peak concentration. That shift can affect TSH monitoring results.

The practical fix is timing. Take levothyroxine on an empty stomach, at least 30 minutes before food and before your GLP-1 dose. If you are on oral semaglutide specifically, your TSH should be rechecked six to eight weeks after starting or after each dose change. Injectable forms carry lower but not absent risk.

Expats managing long-term hypothyroidism without easy access to a home endocrinologist should flag this at their next visit. Takecare Clinic Phuket can run a blood test in Phuket to check thyroid levels the same day.

Oral Contraceptives and GLP-1: What the Evidence Shows

This is the interaction where the two main GLP-1 drugs behave differently, and where the evidence is still developing.

Tirzepatide carries a clear prescribing warning. During dose escalation and for four weeks after each dose increase, women should use a non-oral contraceptive method or add a barrier method alongside the pill. The concern is that delayed gastric emptying reduces absorption of ethinyl estradiol and progestin-based hormones enough to affect contraceptive reliability. This is stated in the Mounjaro prescribing information.

Injectable semaglutide shows a smaller effect on oral contraceptive hormone levels in pharmacokinetic studies, and the current Ozempic labeling does not carry the same formal warning. The risk is not zero, but it is a different risk level than tirzepatide. Women starting tirzepatide who rely on the pill need an alternative plan, particularly during escalation. If you are in Phuket and this applies to you, an English-speaking doctor in Phuket can discuss your options without needing a prior appointment.

Warfarin and GLP-1: INR Monitoring During Dose Changes

Warfarin is sensitive to small changes in how it is absorbed or processed. GLP-1 drugs slow gastric emptying, which delays warfarin absorption and can shift the timing of its peak effect. The total amount absorbed may not change significantly, but the altered timing makes INR levels less predictable during GLP-1 initiation and dose escalation.

The semaglutide FDA label advises increased clinical and laboratory INR monitoring when starting a GLP-1 or changing doses in patients already taking warfarin. Do not adjust your warfarin dose on your own based on a single reading. If you have recently started or increased a GLP-1 drug, your INR should be rechecked sooner than your usual interval. A same-day result is available at Takecare Clinic Phuket if you need it while travelling.

Indirect Interactions: When Nausea and Vomiting Affect Your Other Medications

GLP-1 drugs cause nausea and vomiting in a meaningful proportion of patients, particularly early in treatment. This creates a secondary interaction pathway. If you are vomiting, you may not be absorbing your other oral medications at all, regardless of their individual profiles.

In Phuket’s heat and humidity, this compounds fast. Vomiting plus heat plus reduced appetite equals dehydration, which affects blood pressure, blood glucose concentration, and how the kidneys clear certain medications. Patients on antihypertensives can experience a sharper drop in blood pressure than expected. Patients on metformin should be aware that dehydration and reduced kidney clearance change how metformin behaves in the body.

Dehydration in a tropical climate progresses faster than most visitors from cooler countries expect. If you cannot keep fluids down and you are on multiple medications, that is a clinical situation, not something to manage with rest and coconut water.

A Note on Compounded GLP-1 Products

Compounded semaglutide is available across Southeast Asia, including Thailand, often at a lower price than branded products. The pharmacokinetic data behind the drug interaction guidance, including the levothyroxine exposure figures and the oral contraceptive hormone studies, comes from standardised branded formulations. Compounded products may not behave identically.

This does not mean compounded products are unsafe. It does mean the evidence base for predicting interactions is thinner. If you are using a compounded GLP-1 and you take other regular medications, a medication reconciliation review is more important, not less. The doctor on call service in Phuket at Takecare Clinic can review your full medication list, including compounded products, without needing you to explain the context first.

Before You Start: A Practical Medication Review

Bring a full list of every medication you take, including over-the-counter drugs and supplements. Flag any anticoagulants, thyroid replacements, contraceptives, diabetes medications, antihypertensives, and antidepressants specifically.

Ask whether your GLP-1 formulation is injectable or oral, since the interaction profile differs. Ask whether you are currently in an escalation phase, because that is the highest-risk window. GLP-1 receptor agonists are contraindicated in people with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2. If you are starting a GLP-1 for the first time in Phuket, or you have recently changed your dose and you take any of the drugs mentioned in this article, a medication reconciliation review is the right first step. Walk in, bring your tablets, and we will go through them.